Director at Avalo Therapeutics (AVTX) converts 3,166 RSUs to stock
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Avalo Therapeutics director Gilla Kaplan exercised restricted stock units into common shares. On March 28, 2026, 3,166 restricted stock units converted into 3,166 shares of common stock at a price of $0.00 per share, reflecting a routine compensation-related equity conversion rather than an open-market trade.
Following the transaction, Kaplan directly held 6,333 shares of Avalo Therapeutics common stock and 3,167 restricted stock units. The restricted stock units convert into common stock on a one-for-one basis and were part of a 9,500-unit grant made on August 13, 2024, vesting in three equal annual installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
3,166 shares exercised/converted
Mixed
2 txns
Insider
KAPLAN GILLA
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 3,166 | $0.00 | -- |
| Exercise | Common Stock | 3,166 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 3,167 shares (Direct);
Common Stock — 6,333 shares (Direct)
Footnotes (1)
- Restricted stock units convert into common stock on a one-for-one basis. On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.
Key Figures
RSUs exercised: 3,166 units
Exercise price: $0.00 per share
Common shares after: 6,333 shares
+3 more
6 metrics
RSUs exercised
3,166 units
Restricted stock units converted to common stock on March 28, 2026
Exercise price
$0.00 per share
Conversion price for 3,166 restricted stock units
Common shares after
6,333 shares
Direct common stock holdings following the Form 4 transaction
RSUs remaining
3,167 units
Restricted stock units held after the reported conversion
Original RSU grant
9,500 units
Granted on August 13, 2024, vesting in three annual installments
Vesting dates
March 28, 2025/2026/2027
Scheduled vesting dates for the 9,500-unit RSU grant
Key Terms
Restricted Stock Units, derivative security, vesting, common stock
4 terms
Restricted Stock Units financial
"Restricted stock units convert into common stock on a one-for-one basis."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"Exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vesting financial
"vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
common stock financial
"Restricted stock units convert into common stock on a one-for-one basis."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transaction did Gilla Kaplan report at Avalo Therapeutics (AVTX)?
Gilla Kaplan reported exercising 3,166 restricted stock units into 3,166 shares of Avalo Therapeutics common stock. The units converted at $0.00 per share, reflecting equity compensation vesting rather than an open-market purchase or sale, and increased her directly held common stock position.
What are the terms of Gilla Kaplan’s restricted stock unit grant at Avalo Therapeutics (AVTX)?
On August 13, 2024, Gilla Kaplan was granted 9,500 restricted stock units. These vest in three approximately equal installments on March 28, 2025, March 28, 2026, and March 28, 2027, provided she continues to serve the company through each respective vesting date.